COSMOS Pharmaceutical Corp.

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: JP3298400007
JPY
7,556.00
-172 (-2.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
May'24
May'23
May'22
May'21
May'20
May'19
May'18
Net Sales
9,64,989.00
8,27,697.00
7,55,414.00
7,26,424.00
6,84,403.00
6,11,137.00
5,57,999.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,64,989.00
8,27,697.00
7,55,414.00
7,26,424.00
6,84,403.00
6,11,137.00
5,57,999.00
Raw Material Cost
7,94,951.00
6,74,761.00
6,17,861.00
5,94,114.00
5,61,962.00
5,01,311.00
4,58,569.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
99.00
51.00
52.00
60.00
69.00
77.00
88.00
Selling and Distribution Expenses
1,38,536.00
1,22,807.00
1,07,756.00
99,163.00
93,347.00
85,050.00
76,680.00
Other Expenses
-9.90
-5.10
-5.20
-6.00
-6.90
-7.70
-8.80
Total Expenditure (Excl Depreciation)
9,33,487.00
7,97,568.00
7,25,617.00
6,93,277.00
6,55,309.00
5,86,361.00
5,35,249.00
Operating Profit (PBDIT) excl Other Income
31502
30129
29797
33147
29094
24776
22750
Other Income
2,497.00
2,894.00
3,313.00
6,957.00
2,564.00
2,526.00
2,647.00
Operating Profit (PBDIT)
53,923.00
50,391.00
48,220.00
53,889.00
45,220.00
40,260.00
37,282.00
Interest
99.00
51.00
52.00
60.00
69.00
77.00
88.00
Exceptional Items
-179.00
-198.00
-8.00
-1,448.00
-1,186.00
-86.00
-140.00
Gross Profit (PBDT)
1,70,038.00
1,52,936.00
1,37,553.00
1,32,310.00
1,22,441.00
1,09,826.00
99,430.00
Depreciation
19,924.00
17,368.00
15,110.00
13,785.00
13,562.00
12,958.00
11,885.00
Profit Before Tax
33,719.00
32,773.00
33,048.00
38,596.00
30,402.00
27,139.00
25,167.00
Tax
9,265.00
8,975.00
9,892.00
11,439.00
8,967.00
7,954.00
7,534.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
24,454.00
23,797.00
23,155.00
27,156.00
21,435.00
19,185.00
17,633.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
24,454.00
23,797.00
23,155.00
27,156.00
21,435.00
19,185.00
17,633.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
24,454.00
23,797.00
23,155.00
27,156.00
21,435.00
19,185.00
17,633.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,31,442.00
2,11,072.00
1,90,507.00
1,70,578.00
1,45,675.00
1,26,289.00
1,08,888.00
Earnings per share (EPS)
308.61
300.48
292.37
342.89
270.65
242.24
222.64
Diluted Earnings per share
308.61
300.48
292.37
342.89
270.65
242.24
222.64
Operating Profit Margin (Excl OI)
3.26%
3.64%
3.94%
4.56%
4.25%
4.05%
4.08%
Gross Profit Margin
5.56%
6.06%
6.38%
7.21%
6.42%
6.56%
6.64%
PAT Margin
2.53%
2.88%
3.07%
3.74%
3.13%
3.14%
3.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended May 2024 is 16.59% vs 9.57% in May 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended May 2024 is 2.76% vs 2.77% in May 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended May 2024 is 8.27% vs 5.77% in May 2023

stock-summary

Interest

YoY Growth in year ended May 2024 is 94.12% vs -1.92% in May 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended May 2024 has fallen from May 2023

Compare Annual Results Of COSMOS Pharmaceutical Corp. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
9,64,989.00
12,85,005.00
-3,20,016.00
-24.90%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,64,989.00
12,85,005.00
-3,20,016.00
-24.90%
Raw Material Cost
7,94,951.00
9,20,587.00
-1,25,636.00
-13.65%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
99.00
785.00
-686.00
-87.39%
Selling and Distribution Expenses
1,38,536.00
3,28,008.00
-1,89,472.00
-57.76%
Other Expenses
-9.90
-78.50
68.60
87.39%
Total Expenditure (Excl Depreciation)
9,33,487.00
12,48,595.00
-3,15,108.00
-25.24%
Operating Profit (PBDIT) excl Other Income
31,502.00
36,410.00
-4,908.00
-13.48%
Other Income
2,497.00
5,077.00
-2,580.00
-50.82%
Operating Profit (PBDIT)
53,923.00
67,735.00
-13,812.00
-20.39%
Interest
99.00
785.00
-686.00
-87.39%
Exceptional Items
-179.00
-14,424.00
14,245.00
98.76%
Gross Profit (PBDT)
1,70,038.00
3,64,418.00
-1,94,380.00
-53.34%
Depreciation
19,924.00
26,248.00
-6,324.00
-24.09%
Profit Before Tax
33,719.00
26,277.00
7,442.00
28.32%
Tax
9,265.00
11,938.00
-2,673.00
-22.39%
Provisions and contingencies
0
0
0.00
Profit After Tax
24,454.00
14,957.00
9,497.00
63.50%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
24,454.00
14,957.00
9,497.00
63.50%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-619.00
619.00
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
24,454.00
14,338.00
10,116.00
70.55%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,31,442.00
2,48,615.00
-17,173.00
-6.91%
Earnings per share (EPS)
308.61
72.18
236.43
327.56%
Diluted Earnings per share
308.61
72.18
236.43
327.56%
Operating Profit Margin (Excl OI)
3.26%
2.83%
0.00
0.43%
Gross Profit Margin
5.56%
4.09%
0.00
1.47%
PAT Margin
2.53%
1.16%
0.00
1.37%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 96,498.90 Million
in May 2024

Figures in Million
stock-summary

YoY Growth in year ended May 2024 is 16.59% vs 9.57% in May 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 2,445.40 Million
in May 2024

Figures in Million
stock-summary

YoY Growth in year ended May 2024 is 2.76% vs 2.77% in May 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5,142.60 Million
in May 2024

Figures in Million
stock-summary

YoY Growth in year ended May 2024 is 8.27% vs 5.77% in May 2023

Annual - Interest
Interest 9.90 Million
in May 2024

Figures in Million
stock-summary

YoY Growth in year ended May 2024 is 94.12% vs -1.92% in May 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.26%
in May 2024

Figures in %
stock-summary

YoY Growth in year ended May 2024 has fallen from May 2023